DYAI - Dyadic Attends Investor Events in December | Benzinga
JUPITER, Fla., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that its management will be attending the following investor events during the month of December:
NobleCon-19
December 3 – 5, 2023
Florida Atlantic University, Boca Raton, FL
Mark Emalfarb, Chief Executive Officer
Presentation: Tuesday, December 5, 2023, 3:00 PM - 3:25 PM
The Benchmark Company's Investor Conference
Thursday, December 7, 2023
The New York Athletic Club
180 Central Park South, New York, NY
If you would like to connect with Dyadic's management at any of the events, you may request a one-on-one meeting at hzosiak@dyadic.com.
About Dyadic International, Inc.
Dyadic International, Inc. is a global biotechnology company focused on building innovative microbial platforms to address the ...